Botulinum toxin type A

Phase 3Completed
1 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hemifacial Spasm

Conditions

Hemifacial Spasm

Trial Timeline

Dec 1, 2005 → Jan 1, 2007

About Botulinum toxin type A

Botulinum toxin type A is a phase 3 stage product being developed by Ipsen for Hemifacial Spasm. The current trial status is completed. This product is registered under clinical trial identifier NCT00276315. Target conditions include Hemifacial Spasm.

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (20)

NCT IDPhaseStatus
NCT03017729Pre-clinicalCompleted
NCT02969356ApprovedCompleted
NCT02020980Pre-clinicalCompleted
NCT02106351Phase 3Completed
NCT01753336Phase 3Completed
NCT01753349Pre-clinicalCompleted
NCT01682148Phase 3Terminated
NCT01313312Phase 3Completed
NCT01251380Phase 3Completed
NCT01251367Phase 3Completed
NCT00455637Phase 2Terminated
NCT00288509Phase 3Completed
NCT00276315Phase 3Completed
NCT00246142Phase 3Completed
NCT00134810Phase 2Completed
NCT00149240Phase 2Completed
NCT00246155Phase 3Completed
NCT00447772Phase 3Completed
NCT00247559Phase 2Completed
NCT00210444Phase 2Completed